Abstract. The effective grain-size of magnetic minerals, and therefore domain type, controls the saturation isothermal remanent magnetization acquisition and subsequent demagnetization response and can be used to create "crossover" plots for paleomagnetic specimens, where %SIRM is plotted as a function of the field applied, using a logarithmic scale. This paper presents templates of such plots for magnetite, pyrrhotite, hematite and goethite, onto which sample data can be plotted for conventional paleomagnetic specimens to characterize their magnetic mineralogy and effective grain-size.
The 7 km2 circular Callander alkaline complex was emplaced into anorthositic and granitic gneisses of the Grenville Province in the Canadian Shield about 575 ± 5 Ma ago at the start of the Cambrian. The complex has not been subsequently metamorphosed or tilted. Detailed alternating-field and thermal step demagnetization of 252 specimens from 29 sites led to the identification of a characteristic A magnetization component with a direction of D = 82.2°, I = 82.7° (α95 = 3.1°, k = 83, N = 26 sites) in 5 sites of mesocratic to leucocratic syenite from the core of the complex, in 5 sites of fenitized host rock from its aureole, and in 16 sites of lamprophyre from radiating dikes. Isothermal remanent-magnetization tests show that the A component is retained by both magnetite and hematite in a complete spectrum of domain sizes. A reversals test suggests and a contact test shows the A component to be primary. Its pole position at 46.3°S, 121.4°E(dp = 5.9°, dm = 6.1°) does not fall on published but poorly defined Cambrian apparent polar wander paths, leading to speculation on an alternative Cambrian path.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.